GPT and Hepatic fibrosis: The observed decline in non-invasive assessment of liver fibrosis might be the result of a combination of factors, including reversal of liver fibrosis (41–43), improvement in hepatocellular inflammation (43–45), normalization of ALT (45, 46), increase in PLT (47–49), and random errors in laboratory testing.